Anna Teresa Benincasa

Anna Teresa Benincasa


Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 August 2012 in International Journal of Audiology
Verified
Journal Article
Closed access
MFmassimo fusconi
massimo fusconi
ACAntonio Chistolini
Antonio Chistolini
AVArmando De Virgilio
Armando De Virgilio
Antonio GrecoAntonio Greco
Antonio Greco
FMFulvio Massaro
Fulvio Massaro
MVMarco de Vincentiis
Marco de Vincentiis
Objective: This aim of this study was to determine the prevalence of thrombophilic risk factors in sudden sensorineural hearing loss, central retinal vein occlusion, and stroke associated with small vessel disease, with the purpose of investigating and reinforcing the vascular hypothesis in the pathogenesis of sudden sensorineural hearing loss. Design: Case-control study. Genetic and acquired risk factors of these three groups were compared with healthy controls. Study sample: Forty-nine, 60, and 101 patients affected respectively by sudden sensorineural hearing loss, central retinal vein occlusion, or stroke associated with small vessel disease, enrolled during a three-year period were compared with 210 healthy controls. Results: The frequency of hyperhomocysteinemia (homocysteine ≥ 15 μmol/L) was higher in each disease group than in controls. A statically significant, albeit weak, correlation between the MTHFR C677T mutation and hyperhomocysteinemia was found in all three diseases. Conclusions: Hyperhomocysteinemia proved to be a risk factor for sudden sensorineural hearing loss. Based on these results, we propose to analyse homocysteine in sudden sensorineural hearing loss patients and, if its values are high, to evaluate the presence of MTHFR C677T mutation.

1 November 2012 in American Journal of Otolaryngology
Verified
Journal Article
Closed access
Antonio GrecoAntonio Greco
Antonio Greco
MFMassimo Fusconi
Massimo Fusconi
GMGian Franco Macri
Gian Franco Macri
CMCaterina Marinelli
Caterina Marinelli
EPElisabetta Polettini
Elisabetta Polettini
MVMarco de Vincentiis
Marco de Vincentiis

19 December 2023 in Journal of Personalized Medicine
Verified
Journal Article
Open access
PDF file
NLNicola Lombardo
Nicola Lombardo
GPGiovanna Piazzetta
Giovanna Piazzetta
NLNadia Lobello
Nadia Lobello
GCGiuseppe Cicala
Giuseppe Cicala
MPMaria Patafi
Maria Patafi
GPGirolamo Pelaia
Girolamo Pelaia
Chronic rhinosinusitis with nasal polyposis (CRSwNP) is an inflammatory disease of the nasal and sinus mucosa. This inflammatory process is supported by a multitude of cytokines, including IL-4, IL-5, and IL-13 produced by Th2 cells, as well as by IgE produced by B lymphocytes in response to a stimulus. Omalizumab is an anti-IgE monoclonal antibody with well-recognized roles in allergic asthma and chronic spontaneous urticaria. The aim of this study was to evaluate the clinical efficacy of omalizumab in a cohort of 13 patients suffering from chronic rhinosinusitis with CRSwNP. The inclusion criteria considered were as follows: 18 years of age, with a diagnosis of chronic rhinosinusitis with severe nasal polyposis expressed by an NPS greater than or equal to 5 and/or a SNOT-22 greater than or equal to 50. In addition, in the enrolled patients, the classic treatment with corticosteroids had to have been suspended due to recurrence after surgery or lack of response. Our results highlighted that omalizumab treatment for 16 weeks improved the parameters analyzed: SNOT-22, NPS, NRS, and NCS. The clinical efficacy of omalizumab was further strengthened by a significant improvement in respiratory function as well as reductions in the nasal polyps’ size and in the associated symptoms.

1 March 2014 in Journal of Voice
Verified
Journal Article
Closed access
MFmassimo fusconi
massimo fusconi
ATAnna Rita Taddei
Anna Rita Taddei
AGAndrea Gallo
Andrea Gallo
MCMichela Conte
Michela Conte
AVArmando De Virgilio
Armando De Virgilio
MVMarco De Vincentiis
Marco De Vincentiis

13 June 2013 in Journal of Neurological Surgery Part B: Skull Base
Verified
Journal Article
Closed access
PDF file
MFMassimo Fusconi
Massimo Fusconi
MCMichela Conte
Michela Conte
MPMartina Pagliarella
Martina Pagliarella
CVChiara De Vincentiis
Chiara De Vincentiis
AVArmando De Virgilio
Armando De Virgilio
ABAnna Teresa Benincasa
Anna Teresa Benincasa
Objective Fibrous dysplasia (FD) is a benign bone disorder in facial bones. This study evaluates the possibility of diagnosing fibrous dysplasia on imaging alone, without biopsy of the lesion, which is often burdensome for the patient. Materials and Methods The authors bring their experience of four cases of bone lesions of the maxillofacial region and present a review of published studies. The imaging techniques evaluated are computed tomography (CT) and magnetic resonance imaging (MRI) with and without contrast. Results The literature review demonstrates that it is impossible to make diagnosis of fibrous dysplasia exclusively by imaging. Radiographic images often show a ground-glass appearance, which is characteristic but not pathognomonic of fibrous dysplasia. Conclusion Although CT and MRI images may in many cases suggest a diagnosis of fibrous dysplasia, histological examination or follow-up imaging should follow.

18 May 2017 in Audiology and Neurotology
Verified
Journal Article
Closed access
ECEdoardo Covelli
Edoardo Covelli
LVLuigi Volpini
Luigi Volpini
FAFrancesca Atturo
Francesca Atturo
ABAnna Teresa Benincasa
Anna Teresa Benincasa
CFChiara Filippi
Chiara Filippi
MBMaurizio Barbara
Maurizio Barbara
Objective: To identify eventual correlations between the effect of low-pressure treatment and endolymphatic hydrops in Ménière patients. Material and Methods: The study group consisted of subjects affected by definite Ménière disease (2015) and a severe degree of disability, who received a ventilation tube with or without a low-pressure treatment before undergoing a surgical procedure (vestibular neurectomy). After the placement of the ventilation tube, the subjects were either left alone with the tube or received 1 month of self-administered low-pressure therapy with a portable device. In all subjects, an electrocochleography (ECochG) was performed and specific questionnaires - Dizziness Handicap Inventory (DHI) and Functional Scale Level (FSL) - were completed before starting either arm of treatment, at the end of treatment, and then 3 and 6 months later. Results: All selected subjects presented with an ECochG pattern that was indicative of endolymphatic hydrops before starting either treatment. At the end of pressure treatment, 80% showed symptomatic improvement while maintaining the hydropic ECochG pattern. At the 3-month control stage, the hydropic pattern resulted normalized (<0.5) in all the improved subjects. Conclusions: Although 1 month of low-pressure treatment provided a positive symptomatological outcome, normalization of the hydropic ECochG parameters occurred only at a later time. Therefore, it is possible to assume that endolymphatic hydrops could be concurrent with a non-symptomatic stage of Ménière disease, and that the anti-hydropic effect of the low-pressure treatment, if any, would present with a certain delay after its completion.